Patent details

EP2026787 Title: TABLET FORMULATION COMPRISING REPAGLINIDE AND METFORMIN

Basic Information

Publication number:
EP2026787
PCT Application Number:
PCT/EP/2007/054510
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077289627
PCT Publication Number:
WO/2007/131930
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TABLET FORMULATION COMPRISING REPAGLINIDE AND METFORMIN
French Title of Invention:
FORMULATION DE COMPRIME COMPRENANT DU REPAGLINIDE ET DE LA METFORMINE
German Title of Invention:
REPAGLINID UND METFORMIN ENTHALTENDE TABLETTEN-FORMULIERUNG
SPC Number:

Dates

Filing date:
10/05/2007
Grant date:
25/12/2013
EP Publication Date:
25/12/2013
PCT Publication Date:
22/11/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/02/2009
EP B1 Publication Date:
25/12/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/05/2014
Expiration date:
10/05/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/05/2007
 
 

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:
FRIEDL Thomas
Address:
Germany (DE)

2

Name:
WADA Koichi
Address:
Japan (JP)

3

Name:
NAKATANI Manabu
Address:
Japan (JP)

4

Name:
FUJITA Hikaru
Address:
Japan (JP)

Priority

1

Priority Number:
06009902
Priority Date:
13/05/2006
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
06121953
Priority Date:
09/10/2006
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/155;
Filing date Document type Number of pages